Q-linea AB (publ) (QLINEA.ST)

SEK 0.97

(-1.62%)

Net Income Summary of Q-linea AB (publ)

  • Q-linea AB (publ)'s latest annual net income in 2023 was -229.36 Million SEK , up 16.83% from previous year.
  • Q-linea AB (publ)'s latest quarterly net income in 2024 Q2 was -65.77 Million SEK , down -17.5% from previous quarter.
  • Q-linea AB (publ) reported an annual net income of -275.77 Million SEK in 2022, down -18.26% from previous year.
  • Q-linea AB (publ) reported an annual net income of -233.18 Million SEK in 2021, down -5.9% from previous year.
  • Q-linea AB (publ) reported a quarterly net income of -65.77 Million SEK for 2024 Q2, down -17.5% from previous quarter.
  • Q-linea AB (publ) reported a quarterly net income of -65.48 Million SEK for 2023 Q2, down -8.08% from previous quarter.

Annual Net Income Chart of Q-linea AB (publ) (2023 - 2016)

Historical Annual Net Income of Q-linea AB (publ) (2023 - 2016)

Year Net Income Net Income Growth
2023 -229.36 Million SEK 16.83%
2022 -275.77 Million SEK -18.26%
2021 -233.18 Million SEK -5.9%
2020 -220.19 Million SEK -23.66%
2019 -178.06 Million SEK -38.73%
2018 -128.35 Million SEK -89.09%
2017 -67.87 Million SEK -12.96%
2016 -60.09 Million SEK 0.0%

Peer Net Income Comparison of Q-linea AB (publ)

Name Net Income Net Income Difference
AddLife AB (publ) 190 Million SEK 220.719%
Biotage AB (publ) 246 Million SEK 193.238%
Bonesupport Holding AB (publ) 245.02 Million SEK 193.611%
Doxa AB (publ) 291.9 Million SEK 178.577%
Elekta AB (publ) 1.3 Billion SEK 117.616%
iZafe Group AB (publ) -32.17 Million SEK -612.87%
Ortivus AB (publ) -18.24 Million SEK -1157.144%
Ortivus AB (publ) -18.24 Million SEK -1157.144%
S2Medical AB (publ) -22.7 Million SEK -910.091%
Synsam AB (publ) 311 Million SEK 173.751%